Skip to main content
Have a personal or library account? Click to login
From Corporate Philanthropy to Creating Shared Value: Big Pharma’s New Business Models in Developing Markets Cover

From Corporate Philanthropy to Creating Shared Value: Big Pharma’s New Business Models in Developing Markets

NIM Marketing Intelligence Review
Volume 8 (2016): Issue 1 (May 2016)
By:   
Open Access
|Apr 2016
Articles in this issue
DOI: https://doi.org/10.1515/gfkmir-2016-0005 | Journal eISSN: 2628-166X (formerly 1865-5866)
Journal RSS Feed
Language: English
Page range: 30 - 35
Published on: Apr 29, 2016
Published by: Nuremberg Institute for Market Decisions
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
Corporate Social Responsibility,
Shared Value,
Sustainability,
Emerging Markets,
Pharma Industry
Related subjects:
Business and economics,
Political economics,
Public finance and fiscal theory,
Business management,
Marketing, sales, customer relations,
Management, organization, corporate governance,
Business management, other

© 2016 N. Craig Smith, published by Nuremberg Institute for Market Decisions
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 8 (2016): Issue 1 (May 2016)
Previous article
Next article